PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Tele-Stewardship SSTI Guideline Cuts Empiric Antipseudomonal Use at a Community Hospital

tele-antimicrobial stewardshipskin and soft tissue infectioncellulitisdiabetic foot infectionantipseudomonal agentspiperacillin-tazobactamcefepimeprospective audit with intervention and feedbackpharmacist interventioncommunity hospitalpre-post studyclinical pharmacy practice Infectious Disease / Antimicrobials

Background Information

Telehealth boosts appropriate antibiotic use for skin infections.

Improving antibiotic prescribing practices is crucial for patient care and reducing resistance. Tele-antimicrobial stewardship led to better empirical antibiotic use for skin and soft tissue infections (SSTIs) at a community hospital. Shows telehealth's role in enhancing antibiotic stewardship, though findings are from a single hospital setting. Telehealth can effectively improve antibiotic prescribing in small hospitals.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Ross J, Chandorkar A

Citation: Ross J, Chandorkar A Impact of tele-antimicrobial stewardship interventions in improving antibiotic prescribing practices in skin and soft tissue infections. Antimicrobial stewardship & healthcare epidemiology : ASHE. 2026;6(1):e267. doi:10.1017/ash.2026.10840

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.